Glenmark Pharmaceuticals Ltd

NSE: GLENMARK BSE: 532296

₹2268.40

(1.07%)

Wed, 14 Oct 2026, 11:13 pm

MTF 5xInvest in Glenmark Pharmaceuticals Ltd with 5x Leverage Buy with MTF

Market Cap (in Cr)64664.73

PE Ratio35.61

Dividend0.22

Health Technology

Pharmaceuticals: Major

24.5K

Glenmark Pharmaceuticals Financials

Income Statement Balance Sheet Cashflow

Particulars	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total revenue	6.76B	11.89B	19.34B	20.40B	24.33B	29.49B	40.21B	50.12B	59.24B	65.22B	75.62B	90.79B	90.74B	97.25B	105.45B	108.58B	123.05B	115.83B	118.13B	133.22B
Gross profit	2.93B	6.53B	11.30B	9.21B	11.12B	13.52B	19.48B	24.43B	30.01B	32.79B	34.05B	49.21B	43.45B	31.91B	34.30B	36.32B	42.39B	36.30B	32.59B	48.15B
Operating expenses (excl. COGS)	-1.82B	-2.73B	-4.07B	-5.77B	-5.83B	-8.55B	-13.32B	-15.61B	-19.21B	-23.94B	-22.36B	-34.60B	-30.82B	-20.40B	-22.15B	-19.67B	-23.57B	-25.29B	-26.09B	-29.19B
Selling/general/admin expenses, total	-1.75B	-2.66B	-3.94B	-5.63B	-5.59B	-8.55B	-13.32B	-15.61B	-19.21B	-23.94B	-22.36B	-34.60B	-30.82B	-20.26B	-21.95B	-19.29B	-23.29B	-25.19B	-26.03B	-28.93B
Research & development	-263.34M	-432.61M	-757.73M	-882.70M	-772.76M	-1.38B	-2.92B	-4.12B	-6.00B	-6.01B	-8.18B	-12.62B	-12.25B	-14.48B	-13.21B	-13.19B	-12.79B	-12.50B	-12.26B	-9.73B
Selling/general/admin expenses, other	-1.49B	-2.23B	-3.18B	-4.75B	-4.81B	-7.17B	-10.40B	-11.49B	-13.22B	-17.93B	-14.18B	-21.98B	-18.57B	-5.78B	-8.75B	-6.10B	-10.51B	-12.69B	-13.77B	-19.20B
Other operating expenses, total	-68.03M	-71.92M	-128.35M	-137.71M	-242.02M	0	0	0	0	0	0	0	0	-142.71M	-197.41M	-386.67M	-277.44M	-101.62M	-63.44M	-256.45M
Operating income	1.11B	3.80B	7.23B	3.44B	5.29B	4.98B	6.16B	8.83B	10.80B	8.84B	11.69B	14.60B	12.63B	11.51B	12.15B	16.65B	18.82B	11.01B	6.50B	18.96B
Non-operating income, total	-20.59M	-227.08M	-196.90M	-834.72M	-1.45B	-160.40M	-1.28B	-1.49B	-3.83B	-2.90B	-1.64B	-2.00B	-1.97B	1.50B	-1.19B	-2.83B	-4.41B	-8.61B	-6.14B	-4.97B
Interest expense, net of interest capitalized	-181.67M	-398.26M	-710.42M	-1.46B	-1.66B	-1.60B	-1.47B	-1.60B	-1.89B	-1.90B	-1.79B	-2.37B	-2.86B	-3.35B	-3.77B	-3.53B	-2.98B	-3.49B	-5.16B	-2.07B
Interest capitalized	—	—	—	—	0	0	0	0	0	23.47M	25.50M	209.98M	219.25M	187.71M	162.43M	150.00M	0	0	0	0
Non-operating income, excl. interest expenses	161.08M	171.17M	513.51M	1.79B	205.14M	1.44B	181.73M	107.47M	232.18M	-999.50M	200.00M	372.90M	889.87M	6.62B	2.44B	705.60M	1.18B	-5.12B	-977.74M	830.07M
Non-operating interest income	34.48M	14.18M	78.74M	52.44M	14.82M	38.97M	89.12M	42.62M	66.44M	14.31M	75.80M	180.69M	89.36M	27.00M	46.76M	26.47M	94.35M	70.00M	61.76M	439.35M
Miscellaneous non-operating expense	126.61M	156.99M	434.78M	1.74B	190.32M	1.41B	92.61M	64.85M	165.74M	-1.01B	124.20M	192.21M	800.51M	6.59B	2.40B	679.13M	1.08B	-5.19B	-1.04B	390.72M
Unusual income/expense	—	—	—	-1.17B	—	—	—	—	-2.18B	—	-56.11M	—	—	-1.78B	143.22M	0	-2.61B	0	0	-3.73B
Pretax income	1.09B	3.57B	7.03B	2.61B	3.84B	4.82B	4.88B	7.34B	6.97B	5.94B	10.05B	12.60B	10.67B	13.01B	10.96B	13.82B	14.41B	2.40B	364.95M	13.99B
Taxes	-207.09M	-472.62M	-708.60M	-672.42M	-528.46M	-237.20M	-237.84M	-1.11B	-1.51B	-1.19B	-3.03B	-3.44B	-2.93B	-3.76B	-3.20B	-4.12B	-4.48B	-3.29B	-18.67B	-3.52B
Non-controlling/minority interest	0	0	204.00K	-18.09M	-65.61M	-46.25M	-39.59M	-82.57M	-33.28M	700.00K	1.93M	460.00K	-920.00K	-110.00K	-30.00K	-500.00K	-519.38M	-801.55M	-681.46M	-450.00K
After tax other income/expense	0	0	0	0	0	0	0	0	0	0	0	0	0	10.00K	0	0	0	0	0	0
Net income before discontinued operations	879.76M	3.10B	6.32B	1.92B	3.24B	4.53B	4.60B	6.15B	5.42B	4.75B	7.02B	9.16B	7.74B	9.25B	7.76B	9.70B	9.42B	-1.70B	-18.99B	10.47B
Net income	879.76M	3.10B	6.32B	1.92B	3.24B	4.53B	4.60B	6.15B	5.42B	4.75B	7.02B	9.16B	7.74B	9.25B	7.76B	9.70B	9.42B	2.97B	-15.02B	10.47B
Dilution adjustment	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Preferred dividends	15.96M	7.92M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Diluted net income available to common stockholders	863.80M	3.09B	6.32B	1.92B	3.24B	4.53B	4.60B	6.15B	5.42B	4.75B	7.02B	9.16B	7.74B	9.25B	7.76B	9.70B	9.42B	2.97B	-15.02B	10.47B
Basic earnings per share (Basic EPS)	3.64	12.99	25.84	7.7	12.44	16.78	17.03	22.71	20.01	17.52	25.01	32.46	27.44	32.78	27.5	34.38	33.37	10.53	-53.22	37.11
Diluted earnings per share (Diluted EPS)	3.21	11.56	24.96	7.5	12.42	16.76	17.01	22.69	20	17.52	25	32.45	27.43	32.78	27.5	34.38	33.37	10.53	-53.22	37.1
EBITDA	1.35B	4.24B	7.95B	4.48B	6.49B	5.92B	7.14B	10.10B	12.97B	11.44B	14.33B	20.37B	16.17B	14.77B	16.32B	21.09B	23.69B	16.70B	12.32B	23.82B
EBIT	1.11B	3.80B	7.23B	3.44B	5.29B	4.98B	6.16B	8.83B	10.80B	8.84B	11.69B	14.60B	12.63B	11.51B	12.15B	16.65B	18.82B	11.01B	6.50B	18.96B
Total operating expenses	-5.65B	-8.09B	-12.11B	-16.96B	-19.04B	-24.51B	-34.04B	-41.29B	-48.44B	-56.37B	-63.92B	-76.19B	-78.11B	-85.74B	-93.31B	-91.93B	-104.23B	-104.82B	-111.63B	-114.26B
Prepaid expenses	36.05M	—	—	531.74M	491.53M	—	—	—	—	—	—	—	—	1.32B	1.46B	2.20B	2.20B	2.27B	266.90M	1.05B
Deferred income, current	—	—	—	—	—	—	—	—	9.40M	413.08M	192.27M	—	—	—	—	—	—	—	—	—
Capital and operating lease obligations	0	0	0	0	0	0	0	0	0	0	0	0	0	2.31B	2.31B	2.24B	2.00B	1.52B	1.52B	1.86B
Operating lease liabilities	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Deferred tax liabilities	499.93M	812.69M	1.15B	1.05B	1.28B	1.48B	1.50B	1.77B	2.07B	2.80B	2.67B	3.00B	4.63B	68.56M	164.48M	287.49M	314.95M	5.14M	2.80M	585.88M
Deferred income, non-current	0	—	—	0	0	0	743.89M	817.26M	462.32M	1.17B	0	0	0	—	—	—	—	—	—	—
Minority interest	0	0	14.80M	31.55M	130.07M	267.01M	249.98M	243.64M	132.80M	-1.87M	-3.01M	-4.23M	-3.70M	-3.77M	-3.92M	-3.54M	3.51B	3.65B	-3.80M	-3.71M
Change in accrued expenses	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Common dividends paid	-165.59M	-95.31M	-171.75M	0	-100.97M	-125.82M	-126.09M	-642.56M	-631.91M	-634.65M	-678.53M	-678.05M	-678.82M	-678.81M	-685.54M	-704.47M	-926.95M	-1.37B	-1.18B	-704.42M
Preferred dividends paid	-14.00M	-6.94M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Particulars	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total revenue	6.76B	11.89B	19.34B	20.40B	24.33B	29.49B	40.21B	50.12B	59.24B	65.22B	75.62B	90.79B	90.74B	97.25B	105.45B	108.58B	123.05B	115.83B	118.13B	133.22B
Gross profit	2.93B	6.53B	11.30B	9.21B	11.12B	13.52B	19.48B	24.43B	30.01B	32.79B	34.05B	49.21B	43.45B	31.91B	34.30B	36.32B	42.39B	36.30B	32.59B	48.15B
Operating expenses (excl. COGS)	-1.82B	-2.73B	-4.07B	-5.77B	-5.83B	-8.55B	-13.32B	-15.61B	-19.21B	-23.94B	-22.36B	-34.60B	-30.82B	-20.40B	-22.15B	-19.67B	-23.57B	-25.29B	-26.09B	-29.19B
Selling/general/admin expenses, total	-1.75B	-2.66B	-3.94B	-5.63B	-5.59B	-8.55B	-13.32B	-15.61B	-19.21B	-23.94B	-22.36B	-34.60B	-30.82B	-20.26B	-21.95B	-19.29B	-23.29B	-25.19B	-26.03B	-28.93B
Research & development	-263.34M	-432.61M	-757.73M	-882.70M	-772.76M	-1.38B	-2.92B	-4.12B	-6.00B	-6.01B	-8.18B	-12.62B	-12.25B	-14.48B	-13.21B	-13.19B	-12.79B	-12.50B	-12.26B	-9.73B
Selling/general/admin expenses, other	-1.49B	-2.23B	-3.18B	-4.75B	-4.81B	-7.17B	-10.40B	-11.49B	-13.22B	-17.93B	-14.18B	-21.98B	-18.57B	-5.78B	-8.75B	-6.10B	-10.51B	-12.69B	-13.77B	-19.20B
Other operating expenses, total	-68.03M	-71.92M	-128.35M	-137.71M	-242.02M	0	0	0	0	0	0	0	0	-142.71M	-197.41M	-386.67M	-277.44M	-101.62M	-63.44M	-256.45M
Operating income	1.11B	3.80B	7.23B	3.44B	5.29B	4.98B	6.16B	8.83B	10.80B	8.84B	11.69B	14.60B	12.63B	11.51B	12.15B	16.65B	18.82B	11.01B	6.50B	18.96B
Non-operating income, total	-20.59M	-227.08M	-196.90M	-834.72M	-1.45B	-160.40M	-1.28B	-1.49B	-3.83B	-2.90B	-1.64B	-2.00B	-1.97B	1.50B	-1.19B	-2.83B	-4.41B	-8.61B	-6.14B	-4.97B
Interest expense, net of interest capitalized	-181.67M	-398.26M	-710.42M	-1.46B	-1.66B	-1.60B	-1.47B	-1.60B	-1.89B	-1.90B	-1.79B	-2.37B	-2.86B	-3.35B	-3.77B	-3.53B	-2.98B	-3.49B	-5.16B	-2.07B
Interest capitalized	—	—	—	—	0	0	0	0	0	23.47M	25.50M	209.98M	219.25M	187.71M	162.43M	150.00M	0	0	0	0
Non-operating income, excl. interest expenses	161.08M	171.17M	513.51M	1.79B	205.14M	1.44B	181.73M	107.47M	232.18M	-999.50M	200.00M	372.90M	889.87M	6.62B	2.44B	705.60M	1.18B	-5.12B	-977.74M	830.07M
Non-operating interest income	34.48M	14.18M	78.74M	52.44M	14.82M	38.97M	89.12M	42.62M	66.44M	14.31M	75.80M	180.69M	89.36M	27.00M	46.76M	26.47M	94.35M	70.00M	61.76M	439.35M
Miscellaneous non-operating expense	126.61M	156.99M	434.78M	1.74B	190.32M	1.41B	92.61M	64.85M	165.74M	-1.01B	124.20M	192.21M	800.51M	6.59B	2.40B	679.13M	1.08B	-5.19B	-1.04B	390.72M
Unusual income/expense	—	—	—	-1.17B	—	—	—	—	-2.18B	—	-56.11M	—	—	-1.78B	143.22M	0	-2.61B	0	0	-3.73B
Pretax income	1.09B	3.57B	7.03B	2.61B	3.84B	4.82B	4.88B	7.34B	6.97B	5.94B	10.05B	12.60B	10.67B	13.01B	10.96B	13.82B	14.41B	2.40B	364.95M	13.99B
Taxes	-207.09M	-472.62M	-708.60M	-672.42M	-528.46M	-237.20M	-237.84M	-1.11B	-1.51B	-1.19B	-3.03B	-3.44B	-2.93B	-3.76B	-3.20B	-4.12B	-4.48B	-3.29B	-18.67B	-3.52B
Non-controlling/minority interest	0	0	204.00K	-18.09M	-65.61M	-46.25M	-39.59M	-82.57M	-33.28M	700.00K	1.93M	460.00K	-920.00K	-110.00K	-30.00K	-500.00K	-519.38M	-801.55M	-681.46M	-450.00K
After tax other income/expense	0	0	0	0	0	0	0	0	0	0	0	0	0	10.00K	0	0	0	0	0	0
Net income before discontinued operations	879.76M	3.10B	6.32B	1.92B	3.24B	4.53B	4.60B	6.15B	5.42B	4.75B	7.02B	9.16B	7.74B	9.25B	7.76B	9.70B	9.42B	-1.70B	-18.99B	10.47B
Net income	879.76M	3.10B	6.32B	1.92B	3.24B	4.53B	4.60B	6.15B	5.42B	4.75B	7.02B	9.16B	7.74B	9.25B	7.76B	9.70B	9.42B	2.97B	-15.02B	10.47B
Dilution adjustment	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Preferred dividends	15.96M	7.92M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Diluted net income available to common stockholders	863.80M	3.09B	6.32B	1.92B	3.24B	4.53B	4.60B	6.15B	5.42B	4.75B	7.02B	9.16B	7.74B	9.25B	7.76B	9.70B	9.42B	2.97B	-15.02B	10.47B
Basic earnings per share (Basic EPS)	3.64	12.99	25.84	7.7	12.44	16.78	17.03	22.71	20.01	17.52	25.01	32.46	27.44	32.78	27.5	34.38	33.37	10.53	-53.22	37.11
Diluted earnings per share (Diluted EPS)	3.21	11.56	24.96	7.5	12.42	16.76	17.01	22.69	20	17.52	25	32.45	27.43	32.78	27.5	34.38	33.37	10.53	-53.22	37.1
EBITDA	1.35B	4.24B	7.95B	4.48B	6.49B	5.92B	7.14B	10.10B	12.97B	11.44B	14.33B	20.37B	16.17B	14.77B	16.32B	21.09B	23.69B	16.70B	12.32B	23.82B
EBIT	1.11B	3.80B	7.23B	3.44B	5.29B	4.98B	6.16B	8.83B	10.80B	8.84B	11.69B	14.60B	12.63B	11.51B	12.15B	16.65B	18.82B	11.01B	6.50B	18.96B
Total operating expenses	-5.65B	-8.09B	-12.11B	-16.96B	-19.04B	-24.51B	-34.04B	-41.29B	-48.44B	-56.37B	-63.92B	-76.19B	-78.11B	-85.74B	-93.31B	-91.93B	-104.23B	-104.82B	-111.63B	-114.26B
Prepaid expenses	36.05M	—	—	531.74M	491.53M	—	—	—	—	—	—	—	—	1.32B	1.46B	2.20B	2.20B	2.27B	266.90M	1.05B
Deferred income, current	—	—	—	—	—	—	—	—	9.40M	413.08M	192.27M	—	—	—	—	—	—	—	—	—
Capital and operating lease obligations	0	0	0	0	0	0	0	0	0	0	0	0	0	2.31B	2.31B	2.24B	2.00B	1.52B	1.52B	1.86B
Operating lease liabilities	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Deferred tax liabilities	499.93M	812.69M	1.15B	1.05B	1.28B	1.48B	1.50B	1.77B	2.07B	2.80B	2.67B	3.00B	4.63B	68.56M	164.48M	287.49M	314.95M	5.14M	2.80M	585.88M
Deferred income, non-current	0	—	—	0	0	0	743.89M	817.26M	462.32M	1.17B	0	0	0	—	—	—	—	—	—	—
Minority interest	0	0	14.80M	31.55M	130.07M	267.01M	249.98M	243.64M	132.80M	-1.87M	-3.01M	-4.23M	-3.70M	-3.77M	-3.92M	-3.54M	3.51B	3.65B	-3.80M	-3.71M
Change in accrued expenses	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Common dividends paid	-165.59M	-95.31M	-171.75M	0	-100.97M	-125.82M	-126.09M	-642.56M	-631.91M	-634.65M	-678.53M	-678.05M	-678.82M	-678.81M	-685.54M	-704.47M	-926.95M	-1.37B	-1.18B	-704.42M
Preferred dividends paid	-14.00M	-6.94M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0